Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Total Liabilities and Share Holders Equity 2010-2025 | HYPMY

Hypermarcas total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  
Hypermarcas Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $4,553
2023 $4,909
2022 $4,601
2021 $3,672
2020 $3,346
2019 $3,020
2018 $2,888
2017 $3,173
2016 $3,293
2015 $4,831
2014 $5,934
2013 $5,827
2012 $6,516
2011 $8,008
2010 $5,703
2009 $3,194
Hypermarcas Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2025-03-31 $4,153
2024-12-31 $4,553
2024-09-30 $4,665
2024-06-30 $4,861
2024-03-31 $5,103
2023-12-31 $4,909
2023-09-30 $4,971
2023-06-30 $4,810
2023-03-31 $4,335
2022-12-31 $4,601
2022-09-30 $4,302
2022-06-30 $4,250
2022-03-31 $3,899
2021-12-31 $3,672
2021-09-30 $3,838
2021-06-30 $3,503
2021-03-31 $3,288
2020-12-31 $3,346
2020-09-30 $3,177
2020-06-30 $2,917
2020-03-31 $2,734
2019-12-31 $3,020
2019-09-30 $2,736
2019-06-30 $2,686
2019-03-31 $2,742
2018-12-31 $2,888
2018-09-30 $2,603
2018-06-30 $2,751
2018-03-31 $2,985
2017-12-31 $3,173
2017-09-30 $3,140
2017-06-30 $3,267
2017-03-31 $3,386
2016-12-31 $3,293
2016-09-30 $3,842
2016-06-30 $3,720
2016-03-31 $3,422
2015-12-31 $4,831
2015-09-30 $4,238
2015-06-30 $5,032
2015-03-31 $4,642
2014-12-31 $5,934
2014-09-30 $6,003
2014-06-30 $5,892
2014-03-31 $5,444
2013-12-31 $5,827
2013-09-30 $5,825
2013-06-30 $6,225
2013-03-31 $6,344
2012-12-31 $6,516
2012-09-30 $6,380
2012-06-30 $6,780
2012-03-31 $7,393
2011-12-31 $8,008
2011-09-30 $8,385
2011-06-30 $8,608
2011-03-31 $7,833
2010-12-31 $5,703
2010-09-30 $5,112
2010-06-30 $4,570
2010-03-31 $3,578
2009-12-31 $3,194
2009-09-30 $2,336
2009-06-30 $1,757
2009-03-31 $1,563
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.616B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.587B 32.48
Zoetis (ZTS) United States $72.382B 27.01
Daiichi Sankyo, - (DSNKY) Japan $50.265B 25.57
Takeda Pharmaceutical (TAK) Japan $46.360B 9.22
Sandoz Group AG (SDZNY) Switzerland $21.683B 0.00
Summit Therapeutics (SMMT) United States $19.198B 0.00
Merck (MKKGY) Germany $16.795B 12.31
United Therapeutics (UTHR) United States $13.877B 12.28
Shionogi (SGIOY) Japan $13.799B 13.82
Neurocrine Biosciences (NBIX) United States $11.894B 40.74
IPSEN (IPSEY) France $9.790B 0.00
Orion OYJ (ORINY) Finland $9.323B 25.21
Corcept Therapeutics (CORT) United States $8.345B 67.84
Stevanato Group S.p.A (STVN) Italy $6.756B 41.31
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.941B 0.00
Grifols, S.A (GRFS) Spain $5.576B 0.00
Ionis Pharmaceuticals (IONS) United States $5.249B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.875B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.987B 10.47
Crinetics Pharmaceuticals (CRNX) United States $2.786B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.244B 12.14
BioCryst Pharmaceuticals (BCRX) United States $2.216B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.934B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.719B 0.00
Evotec AG (EVO) Germany $1.680B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.659B 0.00
Indivior (INDV) United States $1.553B 6.58
ARS Pharmaceuticals (SPRY) United States $1.471B 0.00
Guardian Pharmacy Services (GRDN) United States $1.389B 0.00
Dyne Therapeutics (DYN) United States $1.329B 0.00
Ocular Therapeutix (OCUL) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.092B 21.84
Harrow (HROW) United States $0.950B 0.00
Ardelyx (ARDX) United States $0.950B 0.00
Collegium Pharmaceutical (COLL) United States $0.927B 5.00
Avadel Pharmaceuticals (AVDL) Ireland $0.883B 0.00
Enliven Therapeutics (ELVN) United States $0.805B 0.00
Cronos Group (CRON) Canada $0.782B 0.00
Xeris Biopharma Holdings (XERS) United States $0.755B 0.00
Akebia Therapeutics (AKBA) United States $0.751B 0.00
AleAnna (ANNA) United States $0.675B 0.00
KalVista Pharmaceuticals (KALV) United States $0.570B 0.00
Elite Pharmaceuticals (ELTP) United States $0.566B 0.00
USANA Health Sciences (USNA) United States $0.548B 11.91
Regulus Therapeutics (RGLS) United States $0.546B 0.00
Xencor (XNCR) United States $0.539B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.499B 0.00
Savara (SVRA) United States $0.491B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.473B 0.00
Zevra Therapeutics (ZVRA) United States $0.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.465B 0.00
Altimmune (ALT) United States $0.463B 0.00
CytoDyn (CYDY) United States $0.424B 0.00
Siga Technologies (SIGA) United States $0.422B 8.82
Oruka Therapeutics (ORKA) United States $0.410B 0.00
Tourmaline Bio (TRML) United States $0.393B 0.00
Verve Therapeutics (VERV) United States $0.389B 0.00
Organogenesis (ORGO) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.339B 9.15
Heron Therapeutics (HRTX) United States $0.282B 0.00
Nature's Sunshine Products (NATR) United States $0.262B 24.19
Aquestive Therapeutics (AQST) United States $0.233B 0.00
MediWound (MDWD) Israel $0.220B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.212B 0.00
ProKidney (PROK) United States $0.208B 0.00
Nanobiotix S.A (NBTX) France $0.172B 0.00
Wellgistics Health (WGRX) United States $0.170B 0.00
OmniAb (OABI) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.166B 0.00
Journey Medical (DERM) United States $0.163B 0.00
4D Molecular Therapeutics (FDMT) United States $0.162B 0.00
Esperion Therapeutics (ESPR) United States $0.157B 0.00
Profound Medical (PROF) Canada $0.154B 0.00
Liminatus Pharma (LIMN) $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.133B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Korro Bio (KRRO) United States $0.130B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Lyell Immunopharma (LYEL) United States $0.123B 0.00
Nektar Therapeutics (NKTR) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
VAXART, INC (VXRT) United States $0.106B 0.00
Achieve Life Sciences (ACHV) Canada $0.105B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
Cardiol Therapeutics (CRDL) Canada $0.091B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.081B 0.00
Champions Oncology (CSBR) United States $0.080B 13.18
Pyxis Oncology (PYXS) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 56.44
ESSA Pharma (EPIX) Canada $0.075B 0.00
Inotiv (NOTV) United States $0.073B 0.00
Surrozen (SRZN) United States $0.068B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.067B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Nutriband (NTRB) United States $0.061B 0.00
Metagenomi (MGX) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
FibroGen (FGEN) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.78
Ainos (AIMD) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00